QI Path Launches AI-driven Risk Intelligence Platform To Transform Risk Mitigation and Regulatory Readiness Across the Drug Development Lifecycle
BOULDER, Colo., May 27, 2025 /PRNewswire/ -- In response to the mounting regulatory, operational, and reputational pressures facing pharmaceutical companies and...